Welcome to #1 DIGITAL HEALTH NEWS Portal

Mobile App for Autism Screening Yields Useful Data

A Duke study of an iPhone app to screen young children for signs of autism has found that the app is easy to use, welcomed by caregivers and good at producing reliable scientific data. The study, described June 1 in an open access journal npj Digital Medicine, points the way to broader, easier access to screening for autism and other neurodevelopmental disorders.

Read more ...

Siemens Healthineers and ScreenPoint Medical Sign Agreement to Jointly Develop AI-Based Applications in Breast Imaging

Siemens Healthineers and ScreenPoint Medical have agreed to partner to develop artificial intelligence based applications for breast imaging. This collaborative arrangement also includes the acquisition of a strategic minority stake in ScreenPoint Medical by Siemens Healthineers.

Read more ...

mHealth as Effective as Clinic-Based Intervention for People with Serious Mental Illness

A mobile health (mHealth) intervention was found to be as effective as a clinic-based group intervention for people with serious mental illness in a new study published online in Psychiatric Services. In a randomized controlled trial, researchers compared an mHealth approach (FOCUS), using mobile phones to deliver intervention, to a more traditional clinic-based group intervention, the Wellness Recovery Action Plan (WRAP).

Read more ...

FDA Takes New Steps to Advance Digital Health, Opening Docket to Solicit Feedback on Software Products

Today, the FDA is opening a docket to solicit feedback on important provisions of the 21st Century Cures Act ("Cures Act"). The Cures Act amended the Federal Food, Drug, and Cosmetic Act to exclude certain medical software functions from the definition of a medical device. Under the Cures Act, Congress excluded specific types of software from FDA regulation, including general wellness software products, electronic patient records and more.

Read more ...

New Computational Tool could Help Optimize Treatment of Alzheimer's Disease

Scientists have developed a novel computational approach that incorporates individual patients' brain activity to calculate optimal, personalized brain stimulation treatment for Alzheimer's disease. Lazaro Sanchez-Rodriguez of the University of Calgary, Canada, and colleagues present their new framework in PLOS Computational Biology.

Read more ...

Ingestible 'Bacteria on a Chip' could Help Diagnose Disease

MIT researchers have built an ingestible sensor equipped with genetically engineered bacteria that can diagnose bleeding in the stomach or other gastrointestinal problems. This "bacteria-on-a-chip" approach combines sensors made from living cells with ultra-low-power electronics that convert the bacterial response into a wireless signal that can be read by a smartphone.

Read more ...

Philips and the Governments of Ethiopia and the Netherlands Sign Seven-Year Agreement to Build Ethiopia's First Specialized Cardiac Care Center

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and the governments of Ethiopia and the Netherlands, today signed a seven-year agreement to build Ethiopia's first specialized Cardiac Care Center to address the critical shortage of cardiology services in Ethiopia. Under the terms of the agreement, valued at approximately 40 million euro, Philips will be responsible for the full turnkey design, construction, equipping and commissioning of the hospital location, as well as staff education and equipment maintenance for five years after completion.

Read more ...

How Blockchain Technology will Change the eHealth Industry

Opinion Article by Michael Krusche, founder and CEO of K&C.
Let's imagine a world where all medical information about a patient is securely kept within a single system, and they can share it with any healthcare professional, without red tape. Until now, such a dream has been impossible. With the help of blockchain, however, all of that will change.

Read more ...

New Study Reveals How Electronic Health Records can Benefit Clinical Trials

The study entitled "Long term extension of a randomised controlled trial of probiotics using electronic health records" led by researchers in the Swansea University Medical School and the College of Human and Health Sciences, was published in Scientific Reports. The findings demonstrate the potential of using anonymised routinely collected electronic health records, such as those linked in SAIL, for more complete trial results.

Read more ...

Innovative Medicines Initiative Launches 100th Project

The Innovative Medicines Initiative (IMI) has launched its 100th project in the form of Hypo-RESOLVE, a 4 year, EUR 26.8 million project on diabetes. The milestone comes as IMI celebrates its 10th anniversary with a series of events and activities. The IMI project portfolio is diverse; many projects, like Hypo-RESOLVE, focus on specific health issues such as diabetes, neurological conditions (including dementia, depression, and pain), cancer, auto-immune diseases (such as rheumatoid arthritis), and infectious diseases (including antimicrobial resistance and Ebola).

Read more ...